Analysis of antigenically important residues in human influenza a virus in terms of B-Cell epitopes

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 8548-8555

  Lees, William D ^a   Moss, David S ^a   Shepherd, Adrian J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SUBSTITUTION; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HEMAGGLUTINATION INHIBITION TEST; INFLUENZA VIRUS A; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RESIDUE ANALYSIS; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ANTIGENS, VIRAL; COMPUTATIONAL BIOLOGY; EPITOPES, B-LYMPHOCYTE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE EVASION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MODELS, MOLECULAR; MUTATION, MISSENSE;

INFLUENZA A VIRUS;

EID: 80052298833     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00579-11     Document Type: Article

References (41)

1. Air, G. M., W. G. Laver, and R. G. Webster. 1990. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase. J. Virol. 64:5797-5803.
2. Bao, Y., et al. 2008. The Influenza Virus Resource at the National Center for Biotechnology Information. J. Virol. 82:596-601.
3. Barbey-Martin, C., et al. 2002. An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 294:70-74.
4. Berman, H. M., et al. 2002. The Protein Data Bank. Acta Crystallogr. D Biol. Crystallogr. 58:899-907.
5. Bush, R.M., W. M. Fitch, C. A. Bender, and N. J. Cox. 1999. Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol. Biol. Evol. 16:1457-1465.
6. Ekiert, D. C., et al. 2009. Antibody recognition of a highly conserved influenza virus epitope. Science 324:246-251.
7. Fleury, D., et al. 1999. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Biol. 6:530-534.
8. Fleury, D., R. S. Daniels, J. J. Skehel, M. Knossow, and T. Bizebard. 2000. Structural evidence for recognition of a single epitope by two distinct antibodies. Proteins 40:572-578.
9. Fleury, D., S. A. Wharton, J. J. Skehel, M. Knossow, and T. Bizebard. 1998. Antigen distortion allows influenza virus to escape neutralization. Nat. Struct. Biol. 5:119-123.
10. Gamblin, S. J., et al. 2004. The structure and receptor-binding properties of the 1918 influenza hemagglutinin. Science 303:1838-1842.
11. Gershoni, J. M., A. Roitburd-Berman, D. D. Siman-Tov, N. T. Freund, and Y. Weiss. 2007. Epitope mapping: the first step in developing epitope-based vaccines. BioDrugs 21:145-156.
12. Guindon, S., and O. Gascuel. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52:696-704.
13. Hardelid, P., et al. 2010. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009. Health Technol. Assess. 14:115-192.
14. Huang, J., C. King, and J. Yang. 2009. Co-evolution positions and rules for antigenic variants of human influenza A/H3N2 viruses. BMC Bioinformatics 10(Suppl. 1):S41.
15. Irving, M. B., O. Pan, and J. K. Scott. 2001. Random-peptide libraries and antigen-fragment libraries for epitope mapping and the development of vaccines and diagnostics. Curr. Opin. Chem. Biol. 5:314-324.
16. Jin, H., et al. 2005. Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/ 2007/99. Virology 336:113-119.
17. Knossow, M., et al. 2002. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302:294-298.
18. Kubota-Koketsu, R., et al. 2009. Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors. Biochem. Biophys. Res. Commun. 387:180-185.
19. Lapedes, A., and R. Farber. 2001. The geometry of shape space: application to influenza. J. Theor. Biol. 212:57-69.
20. Lee, M., and J. S. Chen. 2004. Predicting antigenic variants of influenza A/H3N2 viruses. Emerg. Infect. Dis. 10:1385-1390.
21. Lees, W. D., D. S. Moss, and A. J. Shepherd. 2010. A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2. Bioinformatics 26:1403-1408.
22. Liao, Y., M. Lee, C. Ko, and C. A. Hsiung. 2008. Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus. Bioinformatics 24: 505-512.
23. Matthews, B. W. 1975. Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochim. Biophys. Acta 405:442-451.
24. Okada, J., et al. 2010. Monoclonal antibodies in man that neutralized H3N2 influenza viruses were classified into three groups with distinct strain specificity:1968-1973, 1977-1993 and 1997-2003. Virology 397:322-330.
25. Okada, J., et al. 2011. Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man. J. Gen. Virol. 92(Pt.2):326-335.
26. Rubinstein, N. D., et al. 2008. Computational characterization of B-cell epitopes. Mol. Immunol. 45:3477-3489.
27. Sauter, N. K., et al. 1992. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry 31:9609-9621.
28. Shih, A. C., T. Hsiao, M. Ho, and W. Li. 2007. Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc. Natl. Acad. Sci. U. S. A. 104:6283-6288.
29. Smith, D. J., et al. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376.
30. Squires, B., et al. 2008. BioHealthBase: informatics support in the elucidation of influenza virus host pathogen interactions and virulence. Nucleic Acids Res. 36:D497-D503.
31. Sui, J., et al. 2009. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16:265-273.
32. Vita, R., et al. 2010. The immune epitope database 2.0. Nucleic Acids Res. 38:D854-D862.
33. Wang, T. T., et al. 2010. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. PLoS Pathog. 6:e1000796.
34. Wei, C., et al. 2010. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329:1060-1064.
35. Wiley, D. C., and J. J. Skehel. 1987. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:365-394.
36. Wiley, D. C., I. A. Wilson, and J. J. Skehel. 1981. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289:373-378.
37. Wilson, I. A., and N. J. Cox. 1990. Structural basis of immune recognition of influenza virus hemagglutinin. Annu. Rev. Immunol. 8:737-771.
38. World Health Organization. 2009. Influenza WHO fact sheet no. 211. World Health Organization, Geneva, Switzerland.
39. Wrammert, J., et al. 2011. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208:181-193.
40. Yang, Z. 2000. Maximum likelihood estimation on large phylogenies and analysis of adaptive evolution in human influenza virus A. J. Mol. Evol. 51:423-432.
41. Zhou, R., P. Das, and A. Royyuru. 2008. Single mutation induced H3N2 hemagglutinin antibody neutralization: a free energy perturbation study. J. Phys. Chem. B 112:15813-15820.